(Q58887666)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6228218%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

title

Renal complications of cytotoxic therapy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6228218%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6228218%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

author name string

A R Clarkson

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6228218%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

publication date

1 October 1983

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6228218%20AND%20SRC:MED&resulttype=core&format=json

Australian and New Zealand journal of medicine

29 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6228218%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

volume

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6228218%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6228218%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

page(s)

531-539

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6228218%20AND%20SRC:MED&resulttype=core&format=json

Preliminary clinical experience withcis-diamminedichloroplatinum (II) (NSC 119875, CACP)

29 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.1983.TB02718.X

Long term effect of Cis-Diamminedichloride platinum (CDDP) on renal function and structure in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.1983.TB02718.X

Hypomagnesemia and Renal Magnesium Wasting in Patients Receiving Cisplatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.1983.TB02718.X

Renal and electrolyte disturbances associated with cisplatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.1983.TB02718.X

Toxicity of cis-diamminedichloroplatinum II given in a two-hour outpatient regimen of diuresis and hydration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.1983.TB02718.X

Water intoxication in man after cyclophosphamide therapy. Time course and relation to drug activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.1983.TB02718.X

A fatal case of inappropriate adh secretion induced by cyclophosphamide therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.1983.TB02718.X

Nephrotoxicity of streptozocin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.1983.TB02718.X

Physiologic disposition of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) and 1-(2-chloroethyl)-3-(4-methyl cyclohexyl)-1-nitrosourea (Me CCNU) in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.1983.TB02718.X

Nephrotoxicity of nitrosoureas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.1983.TB02718.X

Chronic Renal Failure in Children Treated with Methyl CCNU

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.1983.TB02718.X

High dose methotrexate with leucovorin rescue. Rationale and spectrum of antitumor activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.1983.TB02718.X

Renal toxicity of methotrexate

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.1983.TB02718.X

Cytosine arabinoside induced gastrointestinal toxic alterations in sequential chemotherapeutic protocols: a clinical-pathologic study of 33 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.1983.TB02718.X

Intravascular haemolysis and renal impairment after blood transfusion in two patients on long-term 5-fluorouracil and mitomycin-C

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.1983.TB02718.X

Microangiopathic anemia observed after treatment of epidermoid carcinoma with mitomycin C and 5-fluorouracil

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.1983.TB02718.X

Renal disease after mitomycin C therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.1983.TB02718.X

Mode of action of antibiotics. II. Drugs affecting nucleic acid and protein synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.1983.TB02718.X

Synthesis of Deoxyribonucleic Acid by Phage-infected Escherichia coli in the Presence of Mitomycin C

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.1983.TB02718.X

Metabolic and toxic effects of mithramycin during tumor therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.1983.TB02718.X

Management of asparaginase induced hemorrhagic pancreatitis complicated by pseudocyst

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.1983.TB02718.X

Intrarenal dynamics in the pathogenesis and prevention of acute urate nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.1983.TB02718.X

Acute tumor lysis syndrome. A review of 37 patients with Burkitt's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.1983.TB02718.X

Xanthine nephropathy in a patient with lymphosarcoma treated with allopurinol

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.1983.TB02718.X

Hyperkalaemia, a sequel to chemotherapy of Burkitt's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.1983.TB02718.X

Hyperphosphatermia and hypocalcemia accompanying rapid cell lysis in a patient with Burkitt's lymphoma and Burkitt cell leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.1983.TB02718.X

Hyperphosphatemia, Hyperphosphaturia and Hypocalcemia in Acute Lymphoblastic Leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.1983.TB02718.X

The kidney as an endocrine organ involved in calcium homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.1983.TB02718.X

Biological activity of 1,25-dihydroxyvitamin D3 in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.1983.TB02718.X

Hyperphosphatemia, hypocalcemia, and transient renal failure. Results of cytotoxic treatment of acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.1983.TB02718.X

Studies of the mechanism by which phosphate infusion lowers serum calcium concentration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.1983.TB02718.X

Hyperphosphatemia and hypocalcemia in Burkitt lymophoma. Complications of chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.1983.TB02718.X

10.1111/J.1445-5994.1983.TB02718.X

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6228218%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

1 reference